Coral Laboratories Ltd Share Price – BSE

Pharmaceuticals, Small Cap

Coral Laboratories announced that the Board of Directors of the Company at its meeting held on 30 May 2026, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 20%) , subject to the approval of the shareholders.

Net profit of Coral Laboratories rose 84.45% to Rs 5.22 crore in the quarter ended March 2026 as against Rs 2.83 crore during the previous quarter ended March 2025. Sales declined 5.87% to Rs 26.48 crore in the quarter ended March 2026 as against Rs 28.13 crore during the previous quarter ended March 2025.

For the full year,net profit declined 32.20% to Rs 16.38 crore in the year ended March 2026 as against Rs 24.16 crore during the previous year ended March 2025. Sales declined 25.31% to Rs 85.90 crore in the year ended March 2026 as against Rs 115.01 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Coral Laboratories will hold a meeting of the Board of Directors of the Company on 30 May 2026.

Net profit of Coral Laboratories declined 54.72% to Rs 2.78 crore in the quarter ended December 2025 as against Rs 6.14 crore during the previous quarter ended December 2024. Sales declined 6.22% to Rs 21.56 crore in the quarter ended December 2025 as against Rs 22.99 crore during the previous quarter ended December 2024.

Powered by Capital Market - Live News